Cargando…
Trends in Monoclonal Antibody Production Using Various Bioreactor Systems
Monoclonal antibodies are widely used as diagnostic reagents and for therapeutic purposes, and their demand is increasing extensively. To produce these proteins in sufficient quantities for commercial use, it is necessary to raise the output by scaling up the production processes. This review descri...
Autores principales: | Jyothilekshmi, I., Jayaprakash, N. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Microbiology and Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705917/ https://www.ncbi.nlm.nih.gov/pubmed/32238761 http://dx.doi.org/10.4014/jmb.1911.11066 |
Ejemplares similares
-
Use of Micro Bioreactor systems to streamline cell line evaluation and upstream process development for monoclonal antibody production
por: Warr, Steve R C, et al.
Publicado: (2011) -
Impact of media and antifoam selection on monoclonal antibody production and quality using a high throughput micro‐bioreactor system
por: Velugula‐Yellela, Sai Rashmika, et al.
Publicado: (2017) -
Single use bioreactors for the clinical production of monoclonal antibodies – a study to analyze the performance of a CHO cell line and the quality of the produced monoclonal antibody
por: Diekmann, Sonja, et al.
Publicado: (2011) -
Microbials for the production of monoclonal antibodies and antibody fragments
por: Spadiut, Oliver, et al.
Publicado: (2014) -
Impacts on product quality attributes of monoclonal antibodies produced in CHO cell bioreactor cultures during intentional mycoplasma contamination events
por: Fratz‐Berilla, Erica J., et al.
Publicado: (2020)